CRL - Financial Reports List - Charles River Laboratories International, Inc. - IntrinsicAlpha

Charles River Laboratories International, Inc. CRL

Healthcare - Medical - Diagnostics & Research - NYSE - US

$ 137.06

-3.37 %

$ 6.73 B

Market Cap

577.05

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-28	-1.08%	-114.07%	-126.15%
Annual Report	FY	10-K	2024-12-28	-1.92%	-95.32%	-63.17%
Quarterly Report	Q3	8-K	2024-09-28	-1.64%	-21.41%	-22.51%
Quarterly Report	Q2	8-K	2024-06-29	-3.19%	-7.25%	2.83%
Quarterly Report	Q1	8-K	2024-03-30	-1.73%	-34.72%	-16.96%
Quarterly Report	Q4	8-K	2023-12-30	-7.85%	-0.17%	-52.48%
Annual Report	FY	10-K	2023-12-30	3.86%	-2.39%	-5.18%
Quarterly Report	Q3	8-K	2023-09-30	3.79%	-9.42%	0.35%
Quarterly Report	Q2	8-K	2023-07-01	8.92%	-11.25%	-12.62%
Quarterly Report	Q1	8-K	2023-04-01	12.63%	10.87%	15.73%

1